Literature DB >> 27325269

Isolation of Mouse and Human Tumor-Associated Macrophages.

Luca Cassetta1, Roy Noy2, Agnieszka Swierczak1, Gaël Sugano1, Harriet Smith3, Lisa Wiechmann4, Jeffrey W Pollard5,6.   

Abstract

The tumor microenvironment is a complex network of cells that support tumor progression and malignancy. It has been demonstrated that tumor cells can educate the immune system to promote a tumor-friendly environment. Among all these immune cells, tumor-associated macrophages (TAMs) are well represented and their presence in mouse models has been shown to promote tumor progression and metastasis. These effects are through the stimulation of angiogenesis, enhancement of tumor cell invasion and intravasation, immunosuppression, and at the metastatic site tumor cell extravasation and growth. However, the precise mechanisms are not fully understood. Furthermore there is limited information on TAMs derived from human cancers. For this reason it is important to be able to extract TAMs from tumors in order to compare their phenotypes, functions, and transcriptomes with normal resident tissue macrophages. Isolation of these cells is challenging due to the lack of markers and standardized protocols. Here we show an optimized protocol for the efficient isolation and extraction of resident macrophages and TAMs from human and mouse tissues by using multicolor flow cytometry. These protocols allow for the extraction of thousands of macrophages in less than 5 h from tissues as small as half a gram. The isolated macrophages can then be used for both "omics" and in vitro studies.

Entities:  

Keywords:  Breast cancer; Flow cytometry; Human; Macrophages; Mouse; TAM; Tissue; Tumor-associated macrophages

Mesh:

Year:  2016        PMID: 27325269      PMCID: PMC5024544          DOI: 10.1007/978-3-319-26666-4_12

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  45 in total

Review 1.  Macrophage plasticity and polarization: in vivo veritas.

Authors:  Antonio Sica; Alberto Mantovani
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

Review 2.  Macrophages in cancer and infectious diseases: the 'good' and the 'bad'.

Authors:  Chiara Porta; Elena Riboldi; Maria Grazia Totaro; Laura Strauss; Antonio Sica; Alberto Mantovani
Journal:  Immunotherapy       Date:  2011-10       Impact factor: 4.196

3.  STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion.

Authors:  Sergei Kusmartsev; Dmitry I Gabrilovich
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

Review 4.  Tumor-associated macrophages: functional diversity, clinical significance, and open questions.

Authors:  Subhra K Biswas; Paola Allavena; Alberto Mantovani
Journal:  Semin Immunopathol       Date:  2013-05-09       Impact factor: 9.623

5.  High numbers of CD68+ tumor-associated macrophages correlate with poor prognosis in extranodal NK/T-cell lymphoma, nasal type.

Authors:  Hua Wang; Pengfei Li; Liang Wang; Zhongjun Xia; HuiQiang Huang; Yue Lu; ZhiMing Li
Journal:  Ann Hematol       Date:  2015-05-21       Impact factor: 3.673

6.  Stromal gene expression predicts clinical outcome in breast cancer.

Authors:  Greg Finak; Nicholas Bertos; Francois Pepin; Svetlana Sadekova; Margarita Souleimanova; Hong Zhao; Haiying Chen; Gulbeyaz Omeroglu; Sarkis Meterissian; Atilla Omeroglu; Michael Hallett; Morag Park
Journal:  Nat Med       Date:  2008-04-27       Impact factor: 53.440

7.  The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma.

Authors:  H O Smith; P S Anderson; D Y Kuo; G L Goldberg; C L DeVictoria; C A Boocock; J G Jones; C D Runowicz; E R Stanley; J W Pollard
Journal:  Clin Cancer Res       Date:  1995-03       Impact factor: 12.531

8.  Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature.

Authors:  Qiong-wen Zhang; Lei Liu; Chang-yang Gong; Hua-shan Shi; Yun-hui Zeng; Xiao-ze Wang; Yu-wei Zhao; Yu-quan Wei
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

9.  High infiltration of tumor-associated macrophages in triple-negative breast cancer is associated with a higher risk of distant metastasis.

Authors:  Zhong-Yu Yuan; Rong-Zhen Luo; Rou-Jun Peng; Shu-Sen Wang; Cong Xue
Journal:  Onco Targets Ther       Date:  2014-08-21       Impact factor: 4.147

10.  Chemokine receptor CX3CR1 contributes to macrophage survival in tumor metastasis.

Authors:  Jiao Zheng; Min Yang; Jianghua Shao; Yanju Miao; Jiahuai Han; Jie Du
Journal:  Mol Cancer       Date:  2013-11-18       Impact factor: 27.401

View more
  27 in total

1.  Ornithine Decarboxylase in Macrophages Exacerbates Colitis and Promotes Colitis-Associated Colon Carcinogenesis by Impairing M1 Immune Responses.

Authors:  Kshipra Singh; Lori A Coburn; Mohammad Asim; Daniel P Barry; Margaret M Allaman; Chanjuan Shi; M Kay Washington; Paula B Luis; Claus Schneider; Alberto G Delgado; M Blanca Piazuelo; John L Cleveland; Alain P Gobert; Keith T Wilson
Journal:  Cancer Res       Date:  2018-05-31       Impact factor: 12.701

2.  Isolation, characterisation and phagocytic function of human macrophages from human peripheral blood.

Authors:  Lidija Gradišnik; Marko Milojević; Tomaž Velnar; Uroš Maver
Journal:  Mol Biol Rep       Date:  2020-09-02       Impact factor: 2.316

3.  Monoclonal antibody Daratumumab promotes macrophage-mediated anti-myeloma phagocytic activity via engaging FC gamma receptor and activation of macrophages.

Authors:  Ying Gao; Lan Li; Yan Zheng; Weihua Zhang; Ben Niu; Yu Li
Journal:  Mol Cell Biochem       Date:  2022-04-10       Impact factor: 3.396

4.  Synthetic Essentiality of Tryptophan 2,3-Dioxygenase 2 in APC-Mutated Colorectal Cancer.

Authors:  Rumi Lee; Jiexi Li; Jun Li; Chang-Jiun Wu; Shan Jiang; Wen-Hao Hsu; Deepavali Chakravarti; Peiwen Chen; Kyle A LaBella; Jing Li; Denise J Spring; Di Zhao; Y Alan Wang; Ronald A DePinho
Journal:  Cancer Discov       Date:  2022-07-06       Impact factor: 38.272

5.  Pigment epithelium-derived factor, an anti-VEGF factor, delays ovarian cancer progression by alleviating polarization of tumor-associated macrophages.

Authors:  Rui Ma; Xiaolin Chu; Yiting Jiang; Qing Xu
Journal:  Cancer Gene Ther       Date:  2022-03-04       Impact factor: 5.854

6.  Macrophages as a potential tumor-microenvironment target for noninvasive imaging of early response to anticancer therapy.

Authors:  Qizhen Cao; Xinrui Yan; Kai Chen; Qian Huang; Marites P Melancon; Gabriel Lopez; Zhen Cheng; Chun Li
Journal:  Biomaterials       Date:  2017-10-21       Impact factor: 12.479

7.  Integrin αvβ8-expressing tumor cells evade host immunity by regulating TGF-β activation in immune cells.

Authors:  Naoki Takasaka; Robert I Seed; Anthony Cormier; Andrew J Bondesson; Jianlong Lou; Ahmed Elattma; Saburo Ito; Haruhiko Yanagisawa; Mitsuo Hashimoto; Royce Ma; Michelle D Levine; Jean Publicover; Rashaun Potts; Jillian M Jespersen; Melody G Campbell; Fraser Conrad; James D Marks; Yifan Cheng; Jody L Baron; Stephen L Nishimura
Journal:  JCI Insight       Date:  2018-10-18

8.  Magnetic Resonance Imaging Is More Sensitive Than PET for Detecting Treatment-Induced Cell Death-Dependent Changes in Glycolysis.

Authors:  Richard L Hesketh; Jiazheng Wang; Alan J Wright; David Y Lewis; Alice E Denton; Richard Grenfell; Jodi L Miller; Robert Bielik; Marcel Gehrung; Maria Fala; Susana Ros; Bangwen Xie; De-En Hu; Kevin M Brindle
Journal:  Cancer Res       Date:  2019-05-14       Impact factor: 12.701

9.  Auranofin Protects Intestine against Radiation Injury by Modulating p53/p21 Pathway and Radiosensitizes Human Colon Tumor.

Authors:  Dhrubajyoti Nag; Payel Bhanja; Randal Riha; Giselle Sanchez-Guerrero; Bruce F Kimler; Terance T Tsue; Chris Lominska; Subhrajit Saha
Journal:  Clin Cancer Res       Date:  2019-04-02       Impact factor: 13.801

10.  Characterization of vaginal immune response to a polypropylene mesh: Diabetic vs. normoglycemic conditions.

Authors:  Rui Liang; Abigail Fisk; Gabrielle King; Leslie Meyn; Xiangwei Xiao; Pamela Moalli
Journal:  Acta Biomater       Date:  2022-03-09       Impact factor: 10.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.